Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.
about
Vitamin D and bone loss in HIVManagement of bone mineral density in HIV-infected patients.Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study.Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients.Monthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort Study
P2860
Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Per oral substitution with 300 ...... kers in HIV-infected patients.
@ast
Per oral substitution with 300 ...... kers in HIV-infected patients.
@en
type
label
Per oral substitution with 300 ...... kers in HIV-infected patients.
@ast
Per oral substitution with 300 ...... kers in HIV-infected patients.
@en
prefLabel
Per oral substitution with 300 ...... kers in HIV-infected patients.
@ast
Per oral substitution with 300 ...... kers in HIV-infected patients.
@en
P2093
P2860
P356
P1476
Per oral substitution with 300 ...... kers in HIV-infected patients.
@en
P2093
Christoph Fux
Jean Pierre Rothen
Madeleine Rothen
Matthias Stahl
Rein Jan Piso
P2860
P2888
P356
10.1186/1471-2334-13-577
P577
2013-12-06T00:00:00Z
P5875
P6179
1045325529